Microglial forkhead box O3a deficiency attenuates LPS-induced neuro-inflammation and depressive-like behaviour

Rikang Wang1, Lianru Ji2, Shun Yuan2

  • 1Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, China.

PubMed
Abstract

Insights

Forkhead box (FOX) O3a regulates microglial inflammation by inhibiting peroxisome proliferator-activated receptor-γ (PPAR-γ), offering a new therapeutic target for depression.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Depression is linked to microglial activation and neuro-inflammation.
  • Peroxisome proliferator-activated receptor-γ (PPAR-γ) is crucial for M2 microglial activation.
  • Forkhead box (FOX) O3a influences mood-related behaviors, but its role in microglial inflammation is unclear.

Purpose of the Study:

  • To investigate the role of microglial FOXO3a/PPAR-γ axis in depression.
  • To elucidate the inflammatory mechanisms involving FOXO3a in brain microglia.

Main Methods:

  • In vitro and in vivo studies using lipopolysaccharide (LPS)-induced depression models.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) and dual-luciferase reporter assays to confirm FOXO3a-PPAR-γ interaction.
  • Analysis of behavioral changes, inflammatory cytokines, microglial phenotype, and morphology.

Main Results:

  • FOXO3a overexpression attenuated PPAR-γ expression and promoted M1 microglial polarization; FOXO3a knockdown had opposite effects.
  • FOXO3a directly binds to PPAR-γ promoters, inhibiting its transcription.
  • FOXO3a activation reduced LPS-induced neuro-inflammation and depression-like behaviors in mice, while PPAR-γ inhibition reversed these effects in FOXO3a-deficient mice.

Conclusions:

  • The FOXO3a/PPAR-γ axis is a key regulator of microglial activation and depression.
  • Targeting this axis presents a novel therapeutic strategy for major depression.
  • Histone deacetylase inhibitors show potential for treating depression via FOXO3a activation.